BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 21, 2015
View Archived Issues
Inotek Pharmaceuticals begin dosing in pivotal phase III study of trabodenoson
Read More
OMT and Armo BioSciences enter into anti-PD-1 antibody agreement
Read More
Kolltan Pharmaceuticals reports efficacy data from phase Ib KTN-3379 trial
Read More
New phase IIa study investigates simeprevir, odalasvir and AL-335 treatment regimen in HCV
Read More
First clinical results presented for novel radiotracer [123/131I]IMAZA
Read More
[111In]CP04 could represent a step forward in medullary thyroid carcinoma imaging
Read More
Arisaph starts phase II trial of niacin analogue ARI-3037-MO in patients with NAFLD or NASH
Read More
HKU and international research teams identify novel PARP-1 complex
Read More
DSMB recommends continuation of phase III study of Vyxeos for AML
Read More
Luc Therapeutics licenses NMDA modulators for depression to Novartis
Read More
Fecal microbiome transplant shows favorable safety profile in HIV-infected subjects
Read More
FDA grants orphan drug designation to receptor-Fc fusion protein for the treatment of ovarian cancer
Read More
Responses seen with avelumab in trials in mesothelioma, gastric/gastroesophageal junction cancer
Read More
Novel NNT gene mutation linked to left ventricular noncompaction
Read More
First-in-human results reveal activity of SYD-985 in patients with solid tumors
Read More
Curis expands cancer drug pipeline
Read More
FDA grants orphan drug designation and fast track status to resunab for cystic fibrosis
Read More
FDA approves Coagadex for hereditary factor X deficiency
Read More
Tris Pharma's Dyanavel XR approved in U.S. for ADHD in children
Read More
Synta terminates phase III trial of ganetespib in NSCLC
Read More
InterMune discloses antifibrotic pyridinones
Read More
Taisho Pharmaceutical patents orexin receptor antagonists
Read More
Sumitomo Dainippon Pharma describes alpha7 nAChR positive allosteric modulators
Read More
Eicosis develops soluble epoxide hydrolase inhibitors
Read More
Medshine Discovery reports hedgehog signaling pathway inhibitors
Read More
